Size-dependent resistance of human tumour spheroids to photodynamic treatment

47Citations
Citations of this article
31Readers
Mendeley users who have this article in their library.

Abstract

Spheroids derived from the human colon adenocarcinoma cell line, WiDr, were exposed to 10 μg ml−1Photofrin II and irradiated with light (700 nm, 50 mWcm−2). Compared with exponentially growing monolayer cultures, cells in spheroids of 100, 250 and 500 /an diameter were respectively 1.8, 2.5 and 22-fold less sensitive. The small resistance of plateau-phase cultures (1.3-fold) was insufficient to account for this marked spheroid size-dependent resistance. For monolayer cultures and for spheroids of 100 and 250 /mi diameter, the results were the same whether irradiations were carried out pre- or post-trypsinisation. However, there was a difference for the largest spheroid size: when irradiations were carried out pre-trypsinisation, spheroids were more resistant than when irradiations were given post-trypsinisation. Drug extraction studies showed that there was no difference in the average drug uptake between cultures of exponentially growing or plateau-phase cells, and 100 μm diameter spheroids while 250 and 500 μm diameter spheroids took up proportionally 0.5 and 0.4 as much drug. Cell contact effects, drug heterogeneity between cells, hypoxia and problems in drug penetration are suggested as possible reasons for the resistance of large spheroids to photodynamic treatment. © The Macmillan Press Ltd., 1989.

Cite

CITATION STYLE

APA

West, C. M. L. (1989). Size-dependent resistance of human tumour spheroids to photodynamic treatment. British Journal of Cancer, 59(4), 510–514. https://doi.org/10.1038/bjc.1989.105

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free